Under a certain age (40-50) life expectancy is infinity due to longevity escape velocity.
Predictor: Dave Blundin · ep#230 "AI CEOs Come Online: Sam Altman's Replacement Plan, Job Loss & 'Solve Everything' Launches |EP #230" · source
Prediction text
Under a certain age (40-50) life expectancy is infinity due to longevity escape velocity. | Well and at the same time if you're under a certain age you know 40 50 your life expectancy is infinity now because of longevity escape velocity. So, so the the risk of driving the the expected life loss is much much bigger by taking chances today than it would have been 20 years ago.
Watch events: Life Biosciences ER-100 Phase 1 first readout (likely late 2026/early 2027)
Verbatim quote
Well and at the same time if you're under a certain age you know 40 50 your life expectancy is infinity now because of longevity escape velocity. So, so the the risk of driving the the expected life loss is much much bigger by taking chances today than it would have been 20 years ago.
Predictor: Dave Blundin
Calibration plot (stated vs observed)
Evidence about this node from Dave Blundin is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).
Reference class
This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.
Probability over time
Milestone chain
- 2026-06-01 → 2031-12-31pendingFirst FDA-approved senolytic therapy with measurable healthspan benefit in clinical trialHow: FDA approves any senolytic, senomorphic, or partial-reprogramming therapy with primary endpoint demonstrating reduction in age-related disease markers or healthspan extension in human Phase 3Source: https://en.wikipedia.org/wiki/Longevity_escape_velocityconf 55%
- 2026-06-01 → 2032-12-31pendingRobust Mouse Rejuvenation (RMR) achieved: 2x healthy lifespan extension from middle ageHow: Peer-reviewed publication demonstrates intervention starting at mouse middle-age (~18 months) doubles remaining healthy lifespan, de Grey's stated precondition for human LEV being ~15-20 years awaySource: https://www.nextbigfuture.com/2021/03/scientific-progress-to-radical-antiaging-aubrey-sees-50-of-longevity-escape-velocity-by-2035conf 55%
- 2027-01-01 → 2032-12-31pendingYamanaka-factor-based partial cellular reprogramming reaches Phase 2 human trialHow: ClinicalTrials.gov registers Phase 2 trial of OSK or OSKM partial-reprogramming therapy (Altos Labs, Retro Biosciences, Calico, NewLimit, etc.) with safety + efficacy endpointsSource: https://longevity.technology/news/longevity-escape-velocity-by-2035-and-it-will-be-free/conf 50%
- 2028-01-01 → 2035-12-31pendingFirst successful human clinical demonstration of biological-age reversal >=5 years (validated biomarker panel)How: Peer-reviewed Phase 2/3 human trial demonstrates statistically significant reduction in epigenetic biological age (Horvath, PhenoAge, GrimAge) by >=5 years sustained 12+ months post-interventionSource: https://www.nmn.com/news/people-over-40-have-50-50-chance-of-never-dying-of-aging-gerontologist-aubrey-de-greyconf 40%
- 2035-06-01 → 2038-12-31pendingAubrey de Grey's stated 50% LEV-by-2036 milestone window checkHow: By end of 2036-2038: aggregate state of biotech/longevity therapies relative to de Grey's stated benchmark, life expectancy gain per calendar year >=1.0 years for any age cohort under continual receipt of best therapiesSource: https://gregcampion.substack.com/p/longevity-escape-velocityconf 40%
- 2040-01-01 → 2055-12-31pendingCascade: Public actuarial life-expectancy data shows life expectancy increase >1 year per calendar year for any developed-country age cohortHow: Government actuarial body (SSA, OECD member nation, Office for National Statistics UK) reports period or cohort life expectancy increase >1.0 years over preceding calendar year, formal definition of LEV achievedSource: https://www.ceotodaymagazine.com/2025/08/dr-aubrey-de-greys-longevity-escape-velocity-when-will-humanity-outrun-aging/conf 35%
What if this resolves?
Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"
Evidence chain
Network propagation neighbors
Top incoming (parents)
Edges that influence THIS node's belief
| Kind | Node | Their prob | P(c|s=T) | P(c|s=F) | Δ implied |
|---|---|---|---|---|---|
| prereq | 233_008 Public school adoption of Alpha model will take place in the — Joe Liemandt | 32.3% | 0.600 | 0.050 | -0.171 |
| prereq | 242_023 World will have 10x more wealth around 2034-2036 — Dave Blundin | 34.2% | 0.600 | 0.050 | -0.161 |
| prereq | 232_057 First person to arrive on moon/Mars will find bed made by Op — Dave Blundin | 34.8% | 0.600 | 0.050 | -0.159 |
| prereq | 242_031 Most large companies' business models will be disrupted in 2 — Peter Diamandis | 36.1% | 0.600 | 0.050 | -0.150 |
| killer | TK03 AI Regulatory Moratorium (EU/US Capability Freeze) | 10.0% | 0.050 | 0.600 | +0.149 |
Top outgoing (children)
Predictions THIS node influences
| Kind | Node | Their prob | P(c|s=T) | P(c|s=F) | Δ implied |
|---|---|---|---|---|---|
| prereq | 230_020 Peter's 14-year-old son Milan will never get a driver's lice — Peter Diamandis | 34.7% | 0.650 | 0.050 | -0.064 |
Ticker exposure
Beneficiaries (24)
Adverse (6)
Prerequisites (29)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| prereq | SEM_027 | Nvidia Data Center revenue +66% YoY, contributing ~90% of $57B fiscal Q3 revenue; >$4.5T market cap entirely underpinned by AI silicon. | Capital Markets | — |
| prereq | SEM_011 | Nvidia became the world's first $5 trillion company (late 2025), operating a near-monopoly on advanced AI chips. | Capital Markets | — |
| prereq | SEM_014 | Nvidia's Arizona-based TSMC factory successfully fabricated cutting-edge semiconductors on US soil for first time in decades (October 2025). | Manufacturing | — |
| prereq | SEM_029 | Blackwell RTX PRO 5000 (72GB) engineered with 50% memory boost over previous generation — deliberate architectural concession for larger AI training. | Semis/Products | — |
| prereq | SEM_012 | Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) across engineering. | AI/Manufacturing | — |
| prereq | SEM_003 | Fierce zero-sum scramble will saturate every available long-term power contract and voltage transformer through rest of decade. | Energy/Compute | — |
| prereq | SEM_004 | Capital should rotate FROM software developers TO data-center compute, power infrastructure, semi supply chains, and repurposed Bitcoin mining facilities. | Investing | — |
| prereq | SEM_013 | Every nation needs to build advanced chip manufacturing capability — sovereign semiconductor production is existential. | Policy/Semis | — |
| prereq | 242_031 | Most large companies' business models will be disrupted in 2-5 years | Markets/Stocks | — |
| prereq | 232_057 | First person to arrive on moon/Mars will find bed made by Optimus robots; robots not astronauts lead exploration. | Robotics | — |
| prereq | 240_028 | Dyson swarm will be the inevitable destiny within 10 years | Space | — |
| prereq | 241_015 | Google and Nvidia will both do incredibly well due to TPU/GPU positioning | Markets/Stocks | — |
| prereq | 242_004 | Musk ecosystem will lap Nvidia by 1-2 orders of magnitude | Markets/Stocks | — |
| prereq | 231_038 | TSMC fabs will come online in 5-6-7 years; Elon won't wait that long. | AI | — |
| prereq | 242_035 | S&P will see massive reshuffling with huge winners; no company can project FCF beyond 5 years | Markets/Stocks | — |
| prereq | 242_023 | World will have 10x more wealth around 2034-2036 | Macro/Economy | — |
| prereq | 242_033 | Companies will race to 80% token spend / 20% salary; good by 2030-2032 | Labor/Jobs | — |
| prereq | 242_016 | TV ad campaign against human driving in 3-5 years will drive voting to ban it | Auto/Transport | — |
| prereq | 233_014 | Over the next 12 years, half of kids will have neural links while others won't, creating divergence. | Biotech/Longevity | — |
| prereq | 242_011 | New non-lithography semiconductor techniques discovered within 1-2 years, manufactured at scale in 5-7 years | AI | — |
| prereq | 246_043 | Earth limited by ASML and constraints to 3-5 years before mining/constructing moves to space. | Space | — |
| prereq | 242_048 | FDA will move to zero clinical trial model given enough Bayesian/computational evidence | Biotech/Longevity | — |
| prereq | 235_018 | Single-person conglomerates with agents running businesses will be common in ~5 years. | Labor/Jobs | — |
| prereq | 233_008 | Public school adoption of Alpha model will take place in the second decade, not the first. | Education | — |
| killer | TK09 | Energy Grid Cap (Data Center Power Wall) | — | — |
| killer | TK05 | Rate Regime Persistence (10y > 5% through 2028) | — | — |
| killer | TK01 | AGI Capability Plateau (2026-27 Training Stall) | — | — |
| killer | TK02 | AI Compute Supply Shock (TSMC/Taiwan Disruption) | — | — |
| killer | TK03 | AI Regulatory Moratorium (EU/US Capability Freeze) | — | — |
Dependents (1)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| prereq | 230_020 | Peter's 14-year-old son Milan will never get a driver's license. | Auto/Transport | — |
Linked documents (1)
| Sim | Source | Title | Market prob | Polarity | Reviewed | Published |
|---|---|---|---|---|---|---|
| 0.779 | manifold | Longevity escape velocity before 2030? | 11% | mentions | pending | 2026-06-04 |
Raw metadata
{
"nia": false,
"qty": "infinity",
"url": "https://www.youtube.com/watch?v=6P0uTDGDr-I",
"mode": "PREDICTION",
"role": "Host",
"caveats": "Depends on continued medical progress",
"context": "if you're under a certain age you know 40 50 your life expectancy is infinity now because of longevity escape velocity.",
"to_year": 2100,
"verbatim": "Well and at the same time if you're under a certain age you know 40 50 your life expectancy is infinity now because of longevity escape velocity. So, so the the risk of driving the the expected life loss is much much bigger by taking chances today than it would have been 20 years ago.",
"conv_cues": "is infinity now",
"direction": "HAPPEN",
"from_year": 2026,
"timeframe": "now (for those under 40-50)",
"conv_level": "HIGH",
"milestones": [
{
"kind": "prereq",
"label": "Nvidia became the world's first $5 trillion company (late 2025), operating a near-monopoly on advanced AI chips.",
"status": "hit",
"weight": 0.5,
"ordinal": -12,
"source_id": "SEM_011",
"expected_date": "2026-04-29",
"observed_date": "2026-04-29"
},
{
"kind": "prereq",
"label": "Nvidia Data Center revenue +66% YoY, contributing ~90% of $57B fiscal Q3 revenue; >$4.5T market cap entirely underpinned by AI silicon.",
"status": "hit",
"weight": 0.5,
"ordinal": -11,
"source_id": "SEM_027",
"expected_date": "2026-04-29",
"observed_date": "2026-04-29"
},
{
"kind": "prereq",
"label": "Nvidia's Arizona-based TSMC factory successfully fabricated cutting-edge semiconductors on US soil for first time in decades (October 2025).",
"status": "hit",
"weight": 0.5,
"ordinal": -10,
"source_id": "SEM_014",
"expected_date": "2026-04-29",
"observed_date": "2026-04-29"
},
{
"kind": "prereq",
"label": "Blackwell RTX PRO 5000 (72GB) engineered with 50% memory boost over previous generation — deliberate architectural concession for larger AI ",
"status": "hit",
"weight": 0.5,
"ordinal": -9,
"source_id": "SEM_029",
"expected_date": "2026-04-29",
"observed_date": "2026-04-29"
},
{
"kind": "prereq",
"label": "Nvidia quadrupled chip production output while only doubling human headcount — achieved by deploying AI coding tools (Cursor, Claude Code) a",
"status": "hit",
"weight": 0.5,
"ordinal": -8,
"source_id": "SEM_012",
"expected_date": "2026-04-29",
"observed_date": "2026-04-29"
},
{
"kind": "llm_pre_event",
"label": "First FDA-approved senolytic therapy with measurable healthspan benefit in clinical trial",
"source": "https://en.wikipedia.org/wiki/Longevity_escape_velocity",
"status": "pending",
"weight": 0.4,
"ordinal": -7,
"source_id": null,
"confidence": 0.55,
"expected_date": "2029-03-16",
"research_origin": "training",
"expected_date_range": {
"to": "2031-12-31",
"from": "2026-06-01"
},
"measurement_criterion": "FDA approves any senolytic, senomorphic, or partial-reprogramming therapy with primary endpoint demonstrating reduction in age-related disease markers or healthspan extension in human Phase 3"
},
{
"kind": "llm_pre_event",
"label": "Robust Mouse Rejuvenation (RMR) achieved: 2x healthy lifespan extension from middle age",
"source": "https://www.nextbigfuture.com/2021/03/scientific-progress-to-radical-antiaging-aubrey-sees-50-of-longevity-escape-velocity-by-2035",
"status": "pending",
"weight": 0.4,
"ordinal": -6,
"source_id": null,
"confidence": 0.55,
"expected_date": "2029-09-15",
"research_origin": "training",
"expected_date_range": {
"to": "2032-12-31",
"from": "2026-06-01"
},
"measurement_criterion": "Peer-reviewed publication demonstr
... (truncated)